Characterized by the expression of CD68, CD163, and stromal cell-derived factor (SDF)-1, among other markers, NLCs have been equated to tumor-associated macrophages (TAMs) and have been seen to be in close contact with CLL cells in lymphoid tissues of patients [7,10,11]. Here, CD163 is linked to B-cell chronic lymphocytic leukemia.